Sugi Predict

Sugi Predict / Compounds / SCHEMBL8736925

SCHEMBL8736925

SCHEMBL8736925

Cn1cc(-c2cccc(-n3cnc4cc(C(C)(C)C)ccc4c3=O)c2C(C)(C)C)cc(NC(C)(C)C)c1=O

nearest known ligand 0.65

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 19/20 0.65
▸ JAK2 O60674 2/20 0.34
▸ NTRK1 P04629 1/20 0.34
▸ LCK P06239 1/20 0.34
▸ LYN P07948 1/20 0.34
▸ RET P07949 1/20 0.34
▸ SRC P12931 1/20 0.34
▸ TEC P42680 1/20 0.34
▸ TXK P42681 1/20 0.34
▸ BLK P51451 1/20 0.34
▸ BMX P51813 1/20 0.34
▸ ITK Q08881 1/20 0.34
▸ KCNH2 Q12809 1/20 0.34
▸ ERBB4 Q15303 1/20 0.34
▸ NTRK2 Q16620 1/20 0.34
▸ CLK2 P49760 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL108070 0.79 BTK (1.00) BTKJAK2NTRK1LCKLYN
SCHEMBL13531792 0.75 BTK (0.44) BTKJAK2NTRK1LCKLYN
SCHEMBL6114249 0.73 BTK (0.68) BTKJAK2NTRK1LCKLYN
SCHEMBL8735617 0.72 BRD4 (0.39) BTK
SCHEMBL8735621 0.69 BTK (0.73) BTK
SCHEMBL15653014 0.69 BTK (0.53) BTKJAK2NTRK1LCKLYN
SCHEMBL8735184 0.69 BTK (0.48) BTKCLK2
SCHEMBL8737459 0.67 BTK (0.61) BTK
SCHEMBL14878012 0.67 BTK (0.37) BTKJAK2
SCHEMBL25111597 0.67 L3MBTL1 (0.46) BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8822457-B2 Inhibitors of bruton's tyrosine kinase ROCHE PALO ALTO LLC (US) 2014-09-02 — — US disclosed
US-20140194413-A1 INHIBITORS OF BRUTON'S TYROSINE KINASE ROCHE PALO ALTO LLC (US) 2014-07-10 — — US disclosed
US-20120129845-A1 Inhibitors of Bruton's Tyrosine Kinase DEWDNEY NOLAN JAMES (HK) 2012-05-24 — — US disclosed
US-8124604-B2 Inhibitors of bruton's tyrosine kinase ROCHE PALO ALTO LLC (US) 2012-02-28 — — US disclosed
US-20110105479-A1 Inhibitors of Bruton's Tyrosine Kinase DEWDNEY NOLAN JAMES 2011-05-05 — — US disclosed
US-7902194-B2 Inhibitors of bruton's tyrosine kinase Roche Palo Alto (US) 2011-03-08 — — US disclosed
US-20090318448-A1 7-Dimethylamino-3-(2-methyl-3-{1-methyl-5-[5-(morpholine-4-carbonyl)-pyridin-2-ylamino]-6-oxo-1,6-dihydro-pyridin-3-yl}-phenyl)-3H-quinazolin-4-one; asthma ; inhibit Btk ROCHE PALO ALTO LLC 2009-12-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110105479-A1 Inhibitors of Bruton's Tyrosine Kinase BTK, SYK, LYN BTK 1/4885JAK2 14/4885NTRK1 1110/4885
US-20090318448-A1 7-Dimethylamino-3-(2-methyl-3-{1-methyl-5-[5-(morpholine-4-carbonyl)-pyridin-2-ylamino]-6-oxo-1,6-dihydro-pyridin-3-yl}-phenyl)-3H-quinazolin-4-one; asthma ; inhibit Btk BTK, LCK, SYK BTK 1/4885JAK2 44/4885NTRK1 1283/4885
US-20120129845-A1 Inhibitors of Bruton's Tyrosine Kinase BTK, SYK, LYN BTK 1/4885JAK2 14/4885NTRK1 1110/4885
US-20140194413-A1 INHIBITORS OF BRUTON'S TYROSINE KINASE BTK, SYK, LYN BTK 1/4885JAK2 14/4885NTRK1 1110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.